Harrow (HROW) Total Non-Current Liabilities (2014 - 2024)

Harrow's (HROW) quarterly Total Non-Current Liabilities came in at $291.2 million in Q3 2024, up 40.04% year-on-year from $208.0 million in Q4 2023, and up 18.5% quarter-over-quarter from $245.7 million in Q2 2024.

Harrow (HROW) Total Non-Current Liabilities (2014 - 2024) Analysis & Trends

Harrow's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $291.2 million for Q3 2024.

  • On a quarterly basis, Total Non-Current Liabilities rose 40.04% year-over-year to $291.2 million in Q3 2024; TTM through Sep 2024 was $291.2 million, a 40.04% increase from a year earlier, with the FY2023 full-year figure at $239.0 million, changed N/A from the prior year.
  • Total Non-Current Liabilities advanced to $291.2 million in Q3 2024 per HROW's latest filing, from $245.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $291.2 million in Q3 2024 and bottomed at $27.6 million in Q1 2021.
  • The 4-year median for Total Non-Current Liabilities is $196.7 million (2023), against an average of $147.1 million.
  • Across the five-year window, Total Non-Current Liabilities decreased 11.21% in 2021 and surged 40.04% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $29.8 million in 2020, then decreased by 7.59% to $27.6 million in 2021, then jumped by 766.65% to $239.0 million in 2023, then rose by 21.82% to $291.2 million in 2024.
  • Per Business Quant, the three latest HROW Total Non-Current Liabilities figures stand at $291.2 million (Q3 2024), $245.7 million (Q2 2024), and $232.6 million (Q1 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 291.21 Mn
Jun 30, 2024 245.74 Mn
Mar 31, 2024 232.62 Mn
Dec 31, 2023 239.04 Mn
Sep 30, 2023 207.95 Mn
Jun 30, 2023 199.66 Mn
Mar 31, 2023 193.70 Mn
Mar 31, 2021 27.58 Mn
Dec 31, 2020 29.85 Mn
Sep 30, 2020 33.74 Mn
Jun 30, 2020 33.26 Mn
Mar 31, 2020 31.07 Mn
Dec 31, 2019 30.87 Mn
Sep 30, 2019 30.17 Mn
Jun 30, 2019 29.36 Mn
Mar 31, 2019 28.68 Mn
Dec 31, 2018 23.90 Mn
Sep 30, 2018 23.04 Mn
Jun 30, 2018 21.80 Mn
Mar 31, 2018 20.32 Mn